ArticleTechniques in coloproctology2026
Development and validation of an interpretable machine learning model for predicting postoperative complications after transanal total mesorectal excision: a multicenter study.
Article in Techniques in coloproctology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThis study aimed to develop and externally validate an interpretable machine learning (ML) model for predicting postoperative complications after transanal total mesorectal excision (taTME).
methodsWe conducted a multicenter case-control study of 245 consecutive patients undergoing taTME at three centers in China. Patients from one center formed the development cohort (n = 185); two independent centers provided an external validation cohort (n = 60). The primary endpoint was any 30-day complication (Clavien-Dindo). Candidate variables were screened with least absolute shrinkage and selection operator (LASSO) and entered into multivariable logistic regression to define features. In total, 11 ML algorithms were trained with tenfold cross-validation; the final model was selected by area under the receiver operating characteristic (ROC) curve (AUC). Discrimination, calibration, decision-curve analysis (DCA), and clinical-impact curves were assessed. Model interpretability was examined with Shapley additive explanations (SHAP).
resultsOverall, 27.8% of patients experienced postoperative complications. Six predictors-postoperative C-reactive protein (CRP), preoperative total protein (TP), smoking history, age group (> 80 years), neoadjuvant therapy, and ASA score-were retained. The AdaBoost classifier performed best (development AUC 0.822; 95% CI, 0.751-0.892). External validation demonstrated higher discrimination (AUC 0.872; 95% CI, 0.771-0.972), with accuracy 83.3%, sensitivity 56.25%, and specificity 94.7%. Calibration and DCA supported clinical utility, and clinical-impact curves indicated favorable threshold behavior. The SHAP analysis identified postoperative CRP as the most influential predictor and provided transparent, individualized risk explanations.
conclusionsWe developed and externally validated a robust and interpretable ML model to predict complications following taTME. By leveraging routinely available clinical variables and providing transparent predictive explanations, this model can aid clinicians in identifying high-risk patients for targeted interventions, thereby potentially improving perioperative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.